US Stock MarketDetailed Quotes
NVNBW ENVVENO MED CORP C/WTS 11/02/2026 (TO PUR COM)
- 1.000
- 0.0000.00%
15min DelayTrading Jul 22 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open1.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares1.25052wk High0.03P/B0Float Cap1.00052wk Low--Dividend TTM0Shs Float1.250Historical High--Div YieldTTM0.00%Amplitude1.000Historical Low--Avg Price1Lot Size
About ENVVENO MED CORP C/WTS 11/02/2026 (TO PUR COM) Company
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Company Profile
SymbolNVNBW
Company NameENVVENO MED CORP C/WTS 11/02/2026 (TO PUR COM)
Listing DateMay 31, 2018
Founded1999
CEOMr. Robert A. Berman
MarketPink Market
Employees31
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address70 Doppler
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-261-2900
Websitehttp://www.hancockjaffe.com
Company Executives
- Name
- Position
- Salary
- Robert A. Berman
- Director and Chief Executive Officer
- 466.48K
- Dr. Marc H. Glickman, M.D.
- Senior Vice President and Chief Medical Officer
- 404.97K
- Craig Glynn
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 228.82K
- Matthew M. Jenusaitis
- Independent Director
- 75.00K
- Dr. Sanjay Shrivastava
- Independent Director
- 75.00K
- Dr. Francis Duhay
- Independent Director
- 70.00K
- Robert C. Gray
- Independent Director
- 77.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg